SAUNDERS BRENT L Insider Trades

Insider Trading History

Track insider trading activity for SAUNDERS BRENT L. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Bausch + Lomb
Bausch + Lomb BLCO
Chairman Of The Board And CEO
Holding Value $15M 978,389 shares
Last Trade
May 22, 2026 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$45.9k 2,886 shares
$15.92
$15.35
Bausch + Lomb
Bausch + Lomb BLCO
CEO And Chairman Of The Board
Holding Value $14.8M 966,575 shares
Last Trade
Mar 06, 2026 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$252k 14,700 shares
$17.14
$15.35
Bausch + Lomb
Bausch + Lomb BLCO
CEO And Chairman Of The Board
Holding Value $15.1M 981,275 shares
Last Trade
Mar 06, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$251k 14,700 shares
$17.06
$15.35
Bausch + Lomb
Bausch + Lomb BLCO
CEO And Chairman Of The Board
Holding Value $14.6M 951,875 shares
Last Trade
Feb 27, 2026 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$451k 24,649 shares
$18.30
$15.35
Bausch + Lomb
Bausch + Lomb BLCO
CEO And Chairman Of The Board
Holding Value $15M 976,524 shares
Last Trade
Feb 26, 2026 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$408k 22,059 shares
$18.49
$15.35
Bausch + Lomb
Bausch + Lomb BLCO
CEO And Chairman Of The Board
Holding Value $15.3M 998,583 shares
Last Trade
Feb 25, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$6.08M 327,102 shares
$18.60
$15.35
Bausch + Lomb
Bausch + Lomb BLCO
CEO And Chairman Of The Board
Holding Value $10.3M 671,481 shares
Last Trade
Feb 23, 2026 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$1.18M 65,444 shares
$17.99
$15.35
Bausch + Lomb
Bausch + Lomb BLCO
CEO And Chairman Of The Board
Holding Value $11.3M 736,925 shares
Last Trade
Aug 05, 2025 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$61.1k 4,231 shares
$14.44
$15.35
Bausch + Lomb
Bausch + Lomb BLCO
CEO And Chairman Of The Board
Holding Value $13.8M 900,000 shares
Last Trade
Jul 21, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.09M 150,000 shares
$13.93
$15.35
ARS Pharmaceuticals
ARS Pharmaceuticals SPRY
Director
Holding Value $272k 30,000 shares
Last Trade
Jun 25, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$518k 30,000 shares
$17.26
$9.07
Beauty Health Company (The)
Beauty Health Company (The) SKIN
other, Chairman
Holding Value $3.66M 5,994,820 shares
Last Trade
Jun 16, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$112k 73,051 shares
$1.54
$0.61
Bausch + Lomb
Bausch + Lomb BLCO
CEO And Chairman Of The Board
Holding Value $11.4M 741,156 shares
Last Trade
May 22, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$248k 22,000 shares
$11.25
$15.35
Bausch + Lomb
Bausch + Lomb BLCO
CEO And Chairman Of The Board
Holding Value $11M 719,156 shares
Last Trade
May 22, 2025 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$248k 22,000 shares
$11.28
$15.35
ARS Pharmaceuticals
ARS Pharmaceuticals SPRY
Director
Holding Value $0 0 shares
Last Trade
May 20, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$1.71M 120,000 shares
$14.25
$9.07
ARS Pharmaceuticals
ARS Pharmaceuticals SPRY
Director
Holding Value $1.09M 120,000 shares
Last Trade
May 20, 2025 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$1.72M 120,000 shares
$14.33
$9.07
ARS Pharmaceuticals
ARS Pharmaceuticals SPRY
Director
Holding Value $4.27M 470,950 shares
Last Trade
May 20, 2025 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$1.72M 120,000 shares
$14.33
$9.07
Bausch + Lomb
Bausch + Lomb BLCO
CEO And Chairman Of The Board
Holding Value $10.7M 697,156 shares
Last Trade
Feb 26, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$9.53M 600,858 shares
$15.86
$15.35
Bausch + Lomb
Bausch + Lomb BLCO
CEO And Chairman Of The Board
Holding Value $8.5M 553,637 shares
Last Trade
Dec 23, 2024 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$1.76M 98,431 shares
$17.83
$15.35
Beauty Health Company (The)
Beauty Health Company (The) SKIN
other, Chairman
Holding Value $3.61M 5,921,769 shares
Last Trade
Aug 12, 2024 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$52.2k 40,450 shares
$1.29
$0.61
Bausch + Lomb
Bausch + Lomb BLCO
CEO And Chairman Of The Board
Holding Value $9.14M 595,169 shares
Last Trade
Aug 05, 2024 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$505k 32,250 shares
$15.66
$15.35

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up